GHSI Guardion Health Sciences, Inc.

Guardion Health Sciences is at the forefront of early detection, intervention and monitoring of numerous eye diseases that have epidemic or near-epidemic profiles and for which there is substantial market potential for the early diagnosis and treatment.

$0.14  -0.01 (-3.77%)
As of 09/26/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Consumer Staples
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  04/05/2019
Outstanding shares:  61,600,803
Average volume:  1,612,584
Market cap:   $8,993,717
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -0.36
PB ratio:   0.30
PS ratio:   0.96
Return on equity:   -82.88%
Net income %:   -263.14%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy